Cita APA (7a ed.)

Pizzuti, L., Barba, M., Mazzotta, M., Krasniqi, E., Maugeri-Saccà, M., Gamucci, T., . . . Vici, P. (2021). The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial. Nature Portfolio.

Cita Chicago Style (17a ed.)

Pizzuti, Laura, et al. The Prognostic Relevance of HER2-positivity Gain in Metastatic Breast Cancer in the ChangeHER Trial. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Pizzuti, Laura, et al. The Prognostic Relevance of HER2-positivity Gain in Metastatic Breast Cancer in the ChangeHER Trial. Nature Portfolio, 2021.